Isothermal amplification components and processes
Inventors
Miller, Andrew P. • Zhang, Honghua
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The technology relates in part to methods and compositions for isothermal amplification of nucleic acids.
Core Innovation
The invention is directed to a method for detecting a target nucleic acid sequence in a sample using isothermal amplification conditions. The method contacts a non-denatured nucleic acid comprising the target nucleic acid sequence with first and second primers capable of hybridizing to first and second strands, respectively, and amplifies the nucleic acid in an isothermal condition using an enzyme having hyperthermophile polymerase activity, thereby generating a nucleic acid amplification product at detectable levels within 10 minutes.
The nucleic acid amplification product includes the sequence of the first primer and the reverse complement thereof, the sequence of the second primer and the reverse complement thereof, and a spacer sequence flanked by the primer-derived sequences and their reverse complements. The spacer sequence is 1 to 10 bases long, and the amplification does not comprise denaturing the non-denatured nucleic acid and does not comprise using any enzyme other than the enzyme having hyperthermophile polymerase activity.
The disclosed approach further includes detecting the nucleic acid amplification product after generation. Detection can be real-time and can utilize molecular beacons with fluorescent readout, and the amplification is performed without thermocycling and, in embodiments described, without added strand-unwinding/recombination proteins under constant temperature conditions.
Claims Coverage
The independent claim set coverage is centered on a single independent method claim for detecting a target nucleic acid sequence using isothermal amplification with a hyperthermophile polymerase activity, producing a specific primer-and-spacer structured amplification product at detectable levels within 10 minutes, followed by detection. The core inventive features are refined in dependent claims by constraints on the hyperthermophile polymerase, constant temperature ranges, spacer length, and fluorescence detection readouts.
Isothermal amplification of non-denatured target nucleic acid with hyperthermophile polymerase
Amplifying a target nucleic acid sequence comprising a first strand and a second strand complementary to each other in an isothermal amplification condition by contacting a non-denatured nucleic acid with a first primer and a second primer and an enzyme having hyperthermophile polymerase activity, thereby generating a nucleic acid amplification product at detectable levels within 10 minutes.
Primer-derived amplification product with 1 to 10 base spacer sequence
Generating a nucleic acid amplification product comprising the sequence of the first primer and the reverse complement thereof, the sequence of the second primer and the reverse complement thereof, and a spacer sequence flanked by the primer-derived sequences and their reverse complements, wherein the spacer sequence is 1 to 10 bases long.
No denaturing and no other enzymes besides hyperthermophile polymerase
Performing the amplifying without denaturing the non-denatured nucleic acid and without using any enzyme other than the enzyme having hyperthermophile polymerase activity.
Detection of the amplification product
Detecting the nucleic acid amplification product after the isothermal amplification.
Overall claim coverage is anchored by isothermal amplification of non-denatured nucleic acid using a hyperthermophile polymerase activity, with a defined amplification product structure, rapid generation to detectable levels within 10 minutes, and subsequent detection, while excluding denaturation and excluding any enzyme other than the hyperthermophile polymerase.
Stated Advantages
Generates a nucleic acid amplification product at detectable levels within 10 minutes.
Amplifies in an isothermal amplification condition without denaturing the non-denatured nucleic acid.
Does not require using any enzyme other than the enzyme having hyperthermophile polymerase activity.
Enables detecting the nucleic acid amplification product, including real-time detection.
Documented Applications
Detection of chlamydia DNA, including C. trachomatis cryptic plasmid, using molecular beacon-based real-time fluorescence detection, with described ESI-MS confirmation and LOD/real-time fluorescence results.
Interested in licensing this patent?